XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring, Impairment, and Related Charges, Net - Summary of Restructuring Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Restructuring Reserve [Roll Forward]    
Beginning balance $ 92  
Restructuring, impairment, and related charges, net 52 $ 23
Non-cash charges (28)  
Cash payments (37)  
Other (5)  
Ending balance 74  
Operating Segments | U.S. Pharmaceutical    
Restructuring Reserve [Roll Forward]    
Beginning balance 15  
Restructuring, impairment, and related charges, net 2 4
Non-cash charges 0  
Cash payments (5)  
Other 0  
Ending balance 12  
Operating Segments | Prescription Technology Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 26  
Restructuring, impairment, and related charges, net 2 7
Non-cash charges 0  
Cash payments (13)  
Other 0  
Ending balance 15  
Operating Segments | Medical-Surgical Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 3  
Restructuring, impairment, and related charges, net 2 1
Non-cash charges 0  
Cash payments (2)  
Other 0  
Ending balance 3  
Operating Segments | International    
Restructuring Reserve [Roll Forward]    
Beginning balance 13  
Restructuring, impairment, and related charges, net 6 2
Non-cash charges (1)  
Cash payments (2)  
Other (5)  
Ending balance 11  
Corporate    
Restructuring Reserve [Roll Forward]    
Beginning balance 35  
Restructuring, impairment, and related charges, net 40 $ 9
Non-cash charges (27)  
Cash payments (15)  
Other 0  
Ending balance 33  
Accrued Liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 66  
Ending balance 44  
Other Non-Current Liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 26  
Ending balance $ 30